The Glucagon Question Retatrutide's glucagon receptor arm is what differentiates it from tirzepatide and raises theoretical concerns about hepatic glucose output, blood pressure, and lipid changesglucagon is a counter-regulatory hormone that normally opposes insulin
Dietary modification represents an important strategy for managing sulfur burps while taking GLP-1 medications
TXNRD1, thioredoxin reductase 1
Notably, the phase 3 ESSENCE trial, not included in the present algorithm because it was published after 31 January, 2025, showed that semaglutide was associated with a significant improvement in MASH and liver fibrosis 11 similar to tirzepatide
Participants received Exendin-9, a compound that blocks the action of GLP-1, at the same time as taking glucose by mouth
Additionally, glutathione is gaining popularity in cosmetic and anti-aging treatments and is often administered via injection to promote skin health and reduce the visible signs of aging